Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Dhexdhexaadiyaha Nadiifnimada Sare
Dhexdhexaadiyeyaasha la xidhiidha saadka saaraha Argatroban:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Magaca Kiimikada | Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
La mid ah | Ethyl (2R,4R) -4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
Lambarka CAS | 74892-82-3 |
Lambarka CAT | RF-PI267 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C9H17NO2 |
Miisaanka Molecular | 171.24 |
Xaalada Maraakiibta | Lagu soo raray Heer kulka jawiga |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Dareere Jaalle ah oo u cad cad |
Diasteroisomer | ≤1.0% |
Daahirnimada / Habka Falanqaynta | ≥98.0% (GC) |
Biraha culus | ≤20pm |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Argatroban (CAS 74863-84-6) |
Xidhmada: Dhalo, Foosto, 25kg/ Foosto, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha iyo soo saaraha Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) oo leh tayo sare leh.Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) waa dhexdhexaad ah sida caadiga ah isku-dhafka Argatroban Monohydrate (CAS 141396-28-3) ama Argatroban (CAS 74892-84-6) ).
Argatroban Monohydrate waa xinjir-horyaal gaar ah, kaas oo ah xinjirowga lidka ku ah heparin, wuxuu ka hortagayaa samaynta thrombi.Argatroban waa daawada xinjirowga lidka ku ah oo ah molecule yar oo toos ah thrombin inhibitor.Sannadkii 2000, argatroban waxa shati ka siisay Maamulka Cuntada iyo Dawooyinka (FDA) ka hortagga ama daawaynta xinjirowga bukaanka qaba heparin-induced thrombocytopenia (HIT).